Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446976 · ClinicalTrials.gov registry record · Phase 1
CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects
A Phase 1 study, sponsored by Celltrion.
- Completed
- Registry status
- Phase 1
- Development phase
- 218
- Enrollment target
NCT03446976: Completed Phase 1 study, sponsored by Celltrion.
NCT03446976 is a Phase 1 study that has completed, run by Celltrion. The registered enrollment target is 218 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (263% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446976, a Phase 1 study, has completed, sponsored by Celltrion.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 218 participants
- Enrollment target
Study Summary
This study compares two administration methods of CT-P13. Half of participants will receive CT-P13 by pre-filled syringe while the other half will receive CT-P13 by auto-injector.
Primary Outcome
Pharmacokinetics will be assessed by AUC
Interventions
- BIOLOGICAL CT-P13 SC Auto-injector
- BIOLOGICAL CT-P13 SC Pre-filled Syringe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2018-07-26 |
| Phase | Phase 1 |
What the finished NCT03446976 record still lists
NCT03446976 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (263% higher).
The record links to 0 conditions, and to 2 interventions - of which CT-P13 SC Auto-injector is the first listed.
NCT03446976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03446976 about?
NCT03446976 is a clinical study titled "CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects". This study compares two administration methods of CT-P13. Half of participants will receive CT-P13 by pre-filled syringe while the other half will receive CT-P13 by auto-injector.
What is the current status of trial NCT03446976?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 218 participants. The study started on 2018-02-21. Estimated completion is 2018-07-26.
What interventions are being tested in trial NCT03446976?
The interventions under investigation include: CT-P13 SC Auto-injector (BIOLOGICAL), CT-P13 SC Pre-filled Syringe (BIOLOGICAL).
Who is sponsoring clinical trial NCT03446976?
This trial is sponsored by Celltrion, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03446976's enrollment target sits among peer trials
218 239th of 2000 higher than 1,761 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI